Isoflavones and Acute-phase Response in Chronic Renal Failure

Summary

This is a randomized, double-blinded dietary intervention in hemodialysis patients to determine the clinical and metabolic effects of soy isoflavones on disease activity, including improvement of blood markers of acute-phase response, and decreased blood levels of markers of metabolic bone disease.

Timeline

Start

—

Primary completion

2003-09

Completion

2003-09

Drugs

Indications